Literature DB >> 26344726

The epigenetic regulation of podocyte function in diabetes.

Syamantak Majumder1, Andrew Advani2.   

Abstract

Chronic hyperglycemia early in the course of diabetes confers a sustained increase in the risk of complications development. In recent years, efforts to understand the molecular basis for this "metabolic memory" have focused on epigenetic mechanisms as a means by which transient high glucose can cause persistent and propagated changes in cell function. For instance, in vascular endothelial cells, smooth muscle cells and peripheral blood cells, temporary exposure to high glucose causes changes in epigenetic marks that promote a shift towards a pro-inflammatory phenotype. However, the influence of epigenetic processes in complications development extends beyond their contribution to metabolic memory. Podocytes, for example, are terminally differentiated cells of the renal glomerulus whose injury is a major contributor to the pathogenesis of nephropathy. Over recent months, several reports have emerged describing the essential actions of histone-modifying enzymes and DNA methylation patterns (the two principal epigenetic mechanisms) in maintaining podocyte integrity, especially under diabetic conditions. Here, we review the known and potential role of epigenetic processes within podocytes, focusing on the evidence linking these processes to oxidative stress, crosstalk with tubule cells, autophagy and slit-pore protein expression. Whether podocytes themselves exhibit a metabolic memory awaits to be seen.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetylation; Epigenetic; Histone; Methylation; Podocyte

Mesh:

Substances:

Year:  2015        PMID: 26344726     DOI: 10.1016/j.jdiacomp.2015.07.015

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  8 in total

1.  DNA Methyltransferase 1 Controls Nephron Progenitor Cell Renewal and Differentiation.

Authors:  Nicola Wanner; Julia Vornweg; Alexander Combes; Sean Wilson; Julia Plappert; Gesa Rafflenbeul; Victor G Puelles; Raza-Ur Rahman; Timur Liwinski; Saskia Lindner; Florian Grahammer; Oliver Kretz; Mary E Wlodek; Tania Romano; Karen M Moritz; Melanie Boerries; Hauke Busch; Stefan Bonn; Melissa H Little; Wibke Bechtel-Walz; Tobias B Huber
Journal:  J Am Soc Nephrol       Date:  2018-12-05       Impact factor: 10.121

Review 2.  Histone Methylation and Oxidative Stress in Cardiovascular Diseases.

Authors:  Xin Yi; Qiu-Xia Zhu; Xing-Liang Wu; Tuan-Tuan Tan; Xue-Jun Jiang
Journal:  Oxid Med Cell Longev       Date:  2022-03-16       Impact factor: 6.543

3.  Peripheral blood methylation profiling of female Crohn's disease patients.

Authors:  Andrew Y F Li Yim; Nicolette W Duijvis; Jing Zhao; Wouter J de Jonge; Geert R A M D'Haens; Marcel M A M Mannens; Adri N P M Mul; Anje A Te Velde; Peter Henneman
Journal:  Clin Epigenetics       Date:  2016-06-08       Impact factor: 6.551

Review 4.  Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.

Authors:  Ranadheer R Dande; Vasil Peev; Mehmet M Altintas; Jochen Reiser
Journal:  J Diabetes Res       Date:  2017-05-17       Impact factor: 4.011

5.  A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction.

Authors:  Chun-Liang Lin; Yung-Chien Hsu; Yu-Ting Huang; Ya-Hsueh Shih; Ching-Jen Wang; Wen-Chih Chiang; Pey-Jium Chang
Journal:  EMBO Mol Med       Date:  2019-05       Impact factor: 12.137

Review 6.  Acetylation Modification During Autophagy and Vascular Aging.

Authors:  Jiaxing Sun; Shi Tai; Liang Tang; Hui Yang; Mingxian Chen; Yichao Xiao; Xuping Li; Zhaowei Zhu; Shenghua Zhou
Journal:  Front Physiol       Date:  2021-03-22       Impact factor: 4.566

7.  Influence of Referral to a Combined Diabetology and Nephrology Clinic on Renal Functional Trends and Metabolic Parameters in Adults With Diabetic Kidney Disease.

Authors:  William P Martin; Tomás P Griffin; David W Lappin; Damian G Griffin; John P Ferguson; Timothy O'Brien; Matthew D Griffin
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2017-09-01

8.  hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy.

Authors:  Shoujun Bai; Xiaoyan Xiong; Bo Tang; Tingting Ji; Xiaoying Li; Xiaolei Qu; Weiliang Li
Journal:  Oxid Med Cell Longev       Date:  2021-06-27       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.